ExoZymes files updated investor presentation for NCTx business; no specific financial data disclosed

EXOZYMES INC.

eXoZymes issued an updated investor presentation dated November 13, 2025, focusing on its NCTx business.
No new financial metrics, guidance, or operational milestones were included in the filing text.
The presentation content was not appended; only the exhibit description was provided.
Investors should review the full presentation for details, which is available as Exhibit 99.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.